NT
Nia Therapeutics, Inc.
SEC filingOther Health Care · Allston, MA
Amount raised$23.6Msold at filing
Total offering$26.5M$2.9M still open
Investors in the raise37count reported to the SEC
FiledJun 3, 2026first sale Dec 22, 2021
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michael KahanaExecutive Officer, Director
Daniel RizzutoExecutive Officer, Director
Jonathan WachterDirector
Daniel UtinExecutive Officer
Larry GreenbergDirector
Milton MorrisDirector
Executive officers, directors and promoters as listed on the Form D.